THE RETAIL BULLETIN - The home of retail news
Click here
Home Page
News Categories
Commentary
Department Stores
Electricals and Tech
Entertainment
Fashion
Food and Drink
General Merchandise
Grocery
Health and Beauty
Home and DIY
Interviews
People Matter
Retail Business Strategy
Property
Retail Solutions
Electricals & Technology
Sports and Leisure
Christmas Ads
Shopping Centres, High Streets & Retail Parks
Retail Events
People in Retail Awards 2024
Retail HR Central 2024
The Future of The High Street 2024
Retail HR Summit
THE Retail Conference
Upcoming Retail Events
Past Retail Events
Retail Insights
Retail Solutions
Advertise
About
Contact
Subscribe for free
Terms and Policies
Privacy Policy
Tapestry makes two new appointments to its board

Tapestry, the parent company of Coach, Kate Spade and Stuart Weitzman, has appointed Kevin Hourican and David Elkins to its board of directors. Hourican is the… View Article

FASHION RETAIL NEWS UK

Tapestry makes two new appointments to its board

Tapestry, the parent company of Coach, Kate Spade and Stuart Weitzman, has appointed Kevin Hourican and David Elkins to its board of directors.

Hourican is the president and chief executive of Sysco Corporation while Elkins is executive vice president and chief financial officer of Bristol Myers Squibb.

Prior to Sysco, Hourican was executive vice president of CVS Health Corporation and president of CVS Pharmacy where he oversaw an $85 billion retail business, including 9,900 retail stores and over 200,000 employees. Prior to that, he held executive leadership roles at Macy’s, including regional director of stores, where he was responsible for the management of 110 department stores in the US Mid-Atlantic region.

Meanwhile, Elkins has been working with Bristol Myers Squibb following the company’s acquisition of Celgene where he was chief financial officer. Prior to that, he served as chief financial officer for Johnson & Johnson’s consumer products, medical devices, and corporate functions. and has also previously worked with AstraZeneca.

Joanne Crevoiserat, chief executive officer of Tapestry, said, “We are pleased to welcome Kevin and David to our board – two proven leaders in driving global growth and transformation at scale. I am confident that their experience and insights will be invaluable, particularly at this exciting time in our company’s history.

“I look forward to working with them as we execute our strategic agenda and position Tapestry as a leader in innovation and shareholder returns for years to come.”

Subscribe For Retail News